phase readout

NCT05669989: International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

ACTIVE_NOT_RECRUITINGupdated 10d ago

community read0 votes

Sponsor: Sanofi. Phase: PHASE2. Conditions: Plasma Cell Myeloma

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 52m ago

Found something off?